Electronic Cigarettes clinical trials at UCSF

2 research studies open to eligible people

Electronic cigarettes are devices that produce vapor that users inhale. UCSF is currently conducting clinical trials to study the short-term cardiovascular effects of different e-liquid pH levels and the use behaviors, chemical exposures, and biological effects of a standardized research electronic cigarette. These studies will help us better understand the health impacts of e-cigarette use.

Showing trials for

  • Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)

    open to eligible people ages 21-70

    This is a crossover study that will examine use behaviors, chemical exposures, and biological effects of Standardized Research Electronic Cigarette (SREC) compared to usual brand e-cigarette use in natural or synthetic nicotine users.

    San Francisco, California

  • Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH

    open to eligible people ages 21-70

    This study will examine the short-term cardiovascular (CV) effects of e-liquid pH in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim of the study is to assess the impact of changes in e-liquid pH on nicotine pharmacokinetics, cardiovascular, and subjective effects of e-cigarettes.

    San Francisco, California and other locations

Our lead scientists for Electronic Cigarettes research studies include .

Last updated: